The Genetic Map: Understanding the Causes of CSD

While all children with Congenital Sodium Diarrhea (CSD) experience severe salt and water loss, the underlying “why” depends on which specific gene is affected. Genetic testing does more than just give the condition a name; it identifies which part of the intestine’s absorption system is malfunctioning, which helps your medical team predict what other symptoms might appear and how the condition might progress ^[1][2].

There are three primary genetic subtypes of CSD. Two are “non-syndromic,” meaning they mostly affect the digestive tract, and one is “syndromic,” meaning it can involve other parts of the body like the eyes and nose ^[3][4]. Working with a genetic counselor can provide a plain-language explanation of recurrence risk for future pregnancies.

SLC9A3: The Broken Sodium-Hydrogen Exchanger

The SLC9A3 gene is responsible for creating a protein called NHE3. Think of NHE3 as a specialized exchanger on the surface of the intestinal wall that pulls sodium into the body while pushing hydrogen ions out ^[5][6].

• How it works: When this gene has a “loss-of-function” mutation, the pump simply does not work. Sodium stays in the intestine, exchanging luminal sodium for intracellular hydrogen ions, and because water follows salt, it causes watery, sodium-rich diarrhea ^[6][7]. This mechanism also helps explain the associated acid-base disturbance.
• Inheritance: This is an autosomal recessive condition. This means a child usually inherits one changed gene from each parent, neither of whom typically has the condition themselves ^[8].
• What to expect: The severity varies widely. Some children require intensive IV fluids early on, while others have been reported to thrive on oral sodium supplements and a normal diet ^[4][8]. However, some children with this subtype have been reported to have a risk of developing Inflammatory Bowel Disease (IBD) as they get older ^[6].

GUCY2C: The Overactive Signal

The GUCY2C gene (not to be confused with GUCY2D, which affects the eyes) controls a receptor in the gut that regulates fluid balance ^[2][9].

• How it works: This is a “gain-of-function” mutation. Instead of the receptor being broken, it is stuck in the “on” position. This creates too much of a signaling molecule called cGMP, which tells the gut to stop absorbing sodium and start pumping out chloride and water ^[2][10].
• Inheritance: This is often an autosomal dominant condition, meaning a child only needs one copy of the changed gene to have the disorder. It can be passed down from a parent or occur for the first time in the child (a de novo mutation) ^[2][10].
• What to expect: Like the SLC9A3 type, these children have been reported to have an increased risk for IBD and arthritis later in life ^[2][11]. While many need intensive support as infants, some see their symptoms improve significantly ^[12].

SPINT2: The Syndromic Form

The SPINT2 gene produces a protective protein called HAI-2. This protein acts like a “brake” on other enzymes (proteases) in the gut ^[13][14].

• How it works: Without enough HAI-2, these enzymes become overactive and damage the intestinal lining. Under a microscope, this damage often looks like small clumps of cells called intestinal tufts ^[1][15].
• Inheritance: This is autosomal recessive, requiring two copies of the changed gene ^[1].
• Extraintestinal Features: Because HAI-2 is needed in other parts of the body, this subtype often includes:
  • Choanal Atresia: A congenital blockage of the nasal passages at the back of the nose that requires urgent neonatal airway assessment ^[3].
  • Corneal Erosions or Keratitis: Painful irritation or cloudiness on the surface of the eye ^[1][3].
• What to expect: This form is often more complex to manage because it involves multiple organ systems. Children with this type may require longer periods of IV nutrition (PN) and need close monitoring by both eye and nose specialists ^[16][1].

Why the Subtype Matters (And What It Doesn’t Tell Us)

Knowing your child’s genetic subtype allows the medical team to move from “treating diarrhea” to “managing a specific condition.” For example, if your child has the SPINT2 mutation, their doctor will know to schedule regular eye exams to catch corneal issues before they cause pain or vision loss ^[1]. If they have the GUCY2C or SLC9A3 type, the focus may eventually shift toward monitoring for intestinal inflammation ^[2][6]. While we do not yet have “gene-fixing” treatments, understanding the mechanism is the first step toward more personalized care ^[17]. However, it is important to understand the limits of using genotype alone to predict outcomes. The specific variant, clinical course, nutrition, complications, and treatment response—not just the gene name—determine prognosis and eventual PN independence.